Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

NCT00001512 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

NIH

Sponsor class

Conditions

B Cell Lymphoma
Follicular Lymphoma
Lymphoma

Interventions

DRUG: Id-KLH Vaccine
DRUG: GM-CSF

Sponsor

National Cancer Institute (NCI)